The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
出版年份 2019 全文链接
标题
The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-04-09
DOI
10.1038/s41388-019-0817-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors
- (2018) Jamie N Mills et al. CURRENT OPINION IN PHARMACOLOGY
- The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
- (2018) Michaela Poliaková et al. Molecular Cancer
- The Warburg effect and drug resistance
- (2016) Bhaskar Bhattacharya et al. BRITISH JOURNAL OF PHARMACOLOGY
- EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape
- (2016) S.-O. Lim et al. CANCER RESEARCH
- AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment
- (2016) N. A. Daurio et al. CANCER RESEARCH
- Exploring miRNA based approaches in cancer diagnostics and therapeutics
- (2016) Shivangi Mishra et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC)
- (2016) Jinjun Ye et al. Molecular BioSystems
- Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
- (2016) X Qu et al. ONCOGENE
- 18F-FDG PET/CT for Monitoring the Response of Breast Cancer to miR-143-Based Therapeutics by Targeting Tumor Glycolysis
- (2016) Ying Miao et al. Molecular Therapy-Nucleic Acids
- MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation
- (2016) L Liu et al. Oncogenesis
- Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma
- (2015) L.-F. Zhang et al. EMBO JOURNAL
- Enhancing Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
- (2015) Stephen R. D. Johnston JNCI-Journal of the National Cancer Institute
- miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
- (2015) X Zhu et al. ONCOGENE
- Enhancing Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
- (2015) Stephen R. D. Johnston JNCI-Journal of the National Cancer Institute
- miR-186 Regulates Glycolysis through Glut1 During the Formation of Cancer-associated Fibroblasts
- (2014) Pan Sun et al. Asian Pacific Journal of Cancer Prevention
- IL-1β-Mediated Repression of microRNA-101 Is Crucial for Inflammation-Promoted Lung Tumorigenesis
- (2014) Lin Wang et al. CANCER RESEARCH
- A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells
- (2014) S Thrane et al. ONCOGENE
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- A novel miR-155/miR-143 cascade controls glycolysis by regulatinghexokinase 2in breast cancer cells
- (2012) Shuai Jiang et al. EMBO JOURNAL
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
- (2012) Cole Trapnell et al. Nature Protocols
- Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer
- (2012) N Sunaga et al. ONCOGENE
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Mechanisms of microRNA-mediated gene regulation
- (2009) Shuang Zhao et al. Science in China. Series C, Life sciences / Chinese Academy of Sciences
- New anti-cancer role for PDK1 inhibitors: preventing resistance to tamoxifen
- (2008) Christian Peifer et al. BIOCHEMICAL JOURNAL
- Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization
- (2008) Elizabeth Iorns et al. BIOCHEMICAL JOURNAL
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- The epidermal growth factor receptor ligands at a glance
- (2008) Marlon R. Schneider et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells
- (2008) Richard J. Santen et al. STEROIDS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now